BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 16082708)

  • 1. Relationship between FEV1 and peak oxygen uptake in children with cystic fibrosis.
    Pianosi P; LeBlanc J; Almudevar A
    Pediatr Pulmonol; 2005 Oct; 40(4):324-9. PubMed ID: 16082708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peak oxygen uptake and mortality in children with cystic fibrosis.
    Pianosi P; Leblanc J; Almudevar A
    Thorax; 2005 Jan; 60(1):50-4. PubMed ID: 15618583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early oxygen uptake recovery following exercise testing in children with chronic chest diseases.
    Stevens D; Oades PJ; Armstrong N; Williams CA
    Pediatr Pulmonol; 2009 May; 44(5):480-8. PubMed ID: 19382220
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of exercise testing in patients with cystic fibrosis.
    Nixon PA; Orenstein DM; Kelsey SF; Doershuk CF
    N Engl J Med; 1992 Dec; 327(25):1785-8. PubMed ID: 1435933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of a program of hospital-supervised physical training in patients with cystic fibrosis.
    Turchetta A; Salerno T; Lucidi V; Libera F; Cutrera R; Bush A
    Pediatr Pulmonol; 2004 Aug; 38(2):115-8. PubMed ID: 15211693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating peak oxygen uptake in adolescents with cystic fibrosis.
    Werkman MS; Hulzebos EH; Helders PJ; Arets BG; Takken T
    Arch Dis Child; 2014 Jan; 99(1):21-5. PubMed ID: 23894083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in habitual physical activity and lung function decline in children with cystic fibrosis.
    Schneiderman-Walker J; Wilkes DL; Strug L; Lands LC; Pollock SL; Selvadurai HC; Hay J; Coates AL; Corey M
    J Pediatr; 2005 Sep; 147(3):321-6. PubMed ID: 16182669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Accelerated longitudinal decline of aerobic capacity in healthy older adults.
    Fleg JL; Morrell CH; Bos AG; Brant LJ; Talbot LA; Wright JG; Lakatta EG
    Circulation; 2005 Aug; 112(5):674-82. PubMed ID: 16043637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
    Fitzgerald DA; Hilton J; Jepson B; Smith L
    Pediatrics; 2005 Oct; 116(4):e549-54. PubMed ID: 16147970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal analysis of FEV1 changes related to antibiotic therapy in children with cystic fibrosis.
    Javadpour S; Jones A; Brownlee K
    Ir Med J; 2007; 100(7):529-32. PubMed ID: 17886526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Does carbon dioxide retention during exercise predict a more rapid decline in FEV1 in cystic fibrosis?
    Javadpour SM; Selvadurai H; Wilkes DL; Schneiderman-Walker J; Coates AL
    Arch Dis Child; 2005 Aug; 90(8):792-5. PubMed ID: 16040875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
    Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F;
    Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple breath inert gas washout as a measure of ventilation distribution in children with cystic fibrosis.
    Aurora P; Gustafsson P; Bush A; Lindblad A; Oliver C; Wallis CE; Stocks J
    Thorax; 2004 Dec; 59(12):1068-73. PubMed ID: 15563707
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiopulmonary exercise testing in children with cystic fibrosis: one centre's experience.
    Weir E; Burns PD; Devenny A; Young D; Paton JY
    Arch Dis Child; 2017 May; 102(5):440-444. PubMed ID: 27919886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Timing and driving components of the breathing strategy in children with cystic fibrosis during exercise.
    Keochkerian D; Chlif M; Delanaud S; Gauthier R; Maingourd Y; Ahmaidi S
    Pediatr Pulmonol; 2005 Nov; 40(5):449-56. PubMed ID: 16163725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using index of ventilation to assess response to treatment for acute pulmonary exacerbation in children with cystic fibrosis.
    Robinson PD; Cooper P; Van Asperen P; Fitzgerald D; Selvadurai H
    Pediatr Pulmonol; 2009 Aug; 44(8):733-42. PubMed ID: 19598271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Realities of expectorated sputum collection in the pediatric cystic fibrosis clinic.
    Radhakrishnan DK; Corey M; Dell SD
    Arch Pediatr Adolesc Med; 2007 Jun; 161(6):603-6. PubMed ID: 17548767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis.
    Konstan MW; Morgan WJ; Butler SM; Pasta DJ; Craib ML; Silva SJ; Stokes DC; Wohl ME; Wagener JS; Regelmann WE; Johnson CA;
    J Pediatr; 2007 Aug; 151(2):134-9, 139.e1. PubMed ID: 17643762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors affecting clinical outcome in gastrostomy-fed children with cystic fibrosis.
    Oliver MR; Heine RG; Ng CH; Volders E; Olinsky A
    Pediatr Pulmonol; 2004 Apr; 37(4):324-9. PubMed ID: 15022129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preserved diffusion capacity in children with cystic fibrosis.
    Merkus PJ; Govaere ES; Hop WH; Stam H; Tiddens HA; de Jongste JC
    Pediatr Pulmonol; 2004 Jan; 37(1):56-60. PubMed ID: 14679490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.